Background/Objectives: Studies on human herpesvirus 8 (HHV8) infection in patients with AIDS-associated Kaposi sarcoma (AIDS-KS), from Nigeria are lacking. We examined the seroprevalence of HHV8 infection in patients with AIDS-KS presenting to Ahmadu Bello University Teaching Hospital (ABUTH), Zaria, Nigeria, and also described their clinical presentation. Methods: A total of 20 (11 males and 9 females) histologically confirmed adults with AIDS-KS were recruited consecutively in 2007. The clinical types of lesions, associated diseases, and the AIDS clinical trial group staging of AIDS-KS were noted. Anti-lytic HHV8 antibodies were determined by enzyme-linked immunosorbent assay (ELISA). Results: Kaposi sarcoma skin lesions were diverse but mostly nodules (19 cases) and papules (16). Majority (18 cases) had poor risk AIDS-KS, with 10 (50%) patients having concomitant opportunistic infections and 3 (15%) patients having generalized skin lesions. Females had a more severe disease. Seventeen patients (85%) were HHV8-seropositive. Conclusion: AIDS-KS is associated with high HHV8 infection and presents with a variety of skin manifestations that are often aggressive, advanced, and worse in females.
Antman K, Chang Y. Kaposi’s sarcoma. New Engl J Med.2000; 342(14):1027-1038.
2.
Ablashi DV, Chatlynne LG, Whitman JE, Cesarman E.Spectrum of Kaposi’s sarcoma associated herpesviruses or human herpes virus 8 diseases. Clin Micro Rev. 2002;15(3):439-464.
3.
Schwartz RAKaposi’s sarcoma. E-medicine2008. Available at: www.emedicine.com. Accessed March 13, 2008.
4.
Biggar RJCancer in acquired immunodeficiency syndrome; an epidemiological assessment . Semin Oncol. 1990;17(3):251-260.
5.
Bonnet F., Lewden C., May T., et al. Malignancy related causes of deaths in HIV infected patients in the era of HAART. Cancer. 2004;101(2):317-324.
6.
Dedicoat M., Newton R.Review of the distribution of Kaposi’s sarcoma associated herpesvirus (KSHV) in Africa in relation to incidence of Kaposi’s sarcoma. Bri J Cancer. 2003;88(1):1-3.
7.
Simon V., Ho D., Karim AQHIV/AIDS epidemiology, pathogenesis, prevention and treatment. Lancet. 2006; 368(9534):489-504.
8.
Kagu M., Nggada H., Garandawa H., et al. AIDS associated Kaposi’s Sarcoma in Northeastern Nigeria . Singapore Med J. 2006;47(12):1069-1072.
9.
Iregbu KC, Elegba OUPrevalence of Kaposi’s sarcoma among adult HIV seropositive patients seen in a designated HIV treatment and care centre in Abuja, Nigeria. J Int Assoc Physicians AIDS care. 2006;5(3):115-118.
10.
Agaba P., Idoko J., Agbaji L., Kanki P.Patterns of AIDS related Kaposi’s sarcoma in Jos, Nigeria. 3rd International AIDS society conference on HIV pathogenesis and treatment conference report2005, July 24-27.
11.
Ahmed A., Isa M., Garba HA, Kalayi GD, Muhammad I., Egler LJInfluence of HIV infection on presentation of Kaposi’s sarcoma. Trop doc. 2001;31(1):42-45.
12.
Krown SE, Metroka C., Wernz JCKaposi’s sarcoma in the acquired immune deficiency syndrome; a proposal for uniform evaluation, response and staging criteria. J Clin Oncol. 1989; 7(9):1201-1207.
13.
HHV-8 Herpevirus-8 Kaposi’s sarcoma HHV-8 IgG EIA kit. Cat No; V19HHV8,HHV-428-01 11/07 EN. Available at: www.biotrin.com. Accessed March 2009.
14.
World Health Organisation (WHO).Revised clinical staging and immunological classification of HIV and case definition of HIV surveillance 2006. Available at: www.who.int
15.
Keller R., Zago A., Viara MC, et al. HHV8 infection in patients with AIDS related Kaposi’s sarcoma in Brazil. Braz J Med Biol Res. 2001 ;34(7):879-886.
16.
Kouri V., Eng SM, Rodriguez NE, et al. Seroprevalence of Kaposi’s sarcoma associated herpes virus (KSHV) in various populations in Cuba. Rev Panam Salud Publica . 2004;15(5): 320-325.
17.
Wamburu G., Masenga EJ, Moshi EZ, Schimid G., Kempf W., Orfano CFHIV associated and non-HIV associated types of Kaposi’s sarcoma in an African population in Tanzania; Status of immune suppression and HHV8 seroprevalence . Eur J Dermatol. 2006;16(6):677-682.
18.
Duprez R., Kassa Kelembho E., Plancoulaine S., et al. HHV8 serological markers and viral load in patients with AIDS associated Kaposi’s sarcoma in Central African Republic. J Clin Micro. 2003;43(9):4840-4843.
19.
He J., Bhat G., Kankasa C., et al. Seroprevalence of HHV8 among Zambian women of childbearing age without Kaposi’s sarcoma and mother child pair with Kaposi’s sarcoma . J Infect Dis. 1998;178(6):1787-1790.
20.
Engels EA, Whitby D., Goebel PB, et al. Identifying HHV8 infection performance characteristics of serologic assays. J Acq Immun Def Synd. 2000;23(4):346-354.
21.
Ikpatt OF, Ekanem EE, Calabro L., Ogon PM, Chieco-Bianchi L.Seroprevalence of HHV8 among children attending an emergency room in South eastern Nigeria. Nig J Paediatrics. 2002;29(1): 14-16.
22.
Ioachin HL, Adsay V., Giancotti FR, Dorsett B., Melamed J.Kaposi’s sarcoma of internal organs. A multi-parameter study of 86 cases . Cancer. 1995;75(6):1376-1385.
23.
Onunu AN, Okoduwa C., Eze E., Adeyekun AA, Kubeyinje E., Schwartz RAReport; Kaposi’s sarcoma in Nigeria. Int J Dermatol . 2007;46(3):264-267.
24.
Davis D., Rinderknedit A., Zoeteweji P., et al. Hypoxia induces lytic replication of Kaposi’s sarcoma associated herpesvirus (KSHV). Blood. 2001 ;97(10):3244-3250.
25.
Habib A., Keshinro Gebi U., et al. Clinical presentation of HIV infection in Northern Nigeria and its relationship to CD4 cell counts. Nig Med Pract. 1998;35(1/2):3-8.
26.
Engels EA, Biggar RJ, Marshall VA, et al. Detection and Quantification of Kaposi sarcoma associated herpes virus to predict AIDS associated Kaposi’s sarcoma. AIDS. 2003;17(12): 1847-1851.
27.
Martin JN, Ganem D., Osmund D., Page-Shater RA, Macrae D., Kede H.Sexual transmission and Natural history of Human Herpes virus 8 infection . New Engl J Med. 1998;338(14):948-954.
Gallo R.Some aspects of the Pathogenesis of HIV 1 associated Kaposi’s sarcoma . J Nat Cancer Institute monographs. 1998; 23(109):55-57.
30.
Colman R. and Blackbourn DJRisks factors in the development of Kaposi’s sarcoma. AIDS. 2008;22(13):1629-1632.
31.
Bouman A., Heineman MJ, Faas MMSex hormones and the immune response in humans. Human Rep Update. 2005;11(4): 411-423.
32.
Russell JAManagement of sepsis. N Engl J Med. 2006;355(16): 1699-1713.
33.
Nnoruka E.Epidemic (HIV related) Kaposi’s sarcoma in West African women. Int J Dermat. 2003;42(10):794-799.
34.
Mosam A., Hurchand HP, Cassol E., et al. Characteristics of HIV-1I associated Kaposi’s sarcoma among women and men in South Africa. Int J STD AIDS. 2008;19(6):400-405.
35.
Cooley TP, Hirschnorn LR, O’Keane CJKaposi’s sarcoma in women with AIDS. AIDS. 1996;10(5):1221-1225.
36.
Schuefer H., Roeder C., Ochsenderf FR, Hoshschield I.Kaposi’s sarcoma (HIV+ and HIV-) in Caucasian women. IX International conference on AIDS, Berlin, June, 1993 (Abtract PO: B12-1569).
